Foyston, Gordon & Payne Slashes Allison Transmission Holdings by $7.3 Million as Sales Plunge 28%

Foyston, Gordon & Payne trimmed its Allison Transmission (NYSE: ALSN) stake by 72,651 shares in Q3 2025 (an estimated $7.28M reduction), leaving a 37,954-share position valued at $3.22M that now equals ~0.7041% of the fund's $457.53M 13F reportable assets (down from 2.3921%). Allison reported weak Q3 results—North American On‑Highway sales fell 28% YoY and management lowered full‑year guidance—though EBITDA margin remained strong (~37%) and the Defense segment grew ~47%; the stock traded at $81.98 on 2025-11-11 (market cap ~$6.94B, TTM revenue $3.07B, net income $699M). The block sale signals institutional caution amid near‑term commercial vehicle weakness and ongoing strategic activity (Dana Off‑Highway acquisition), so monitor guidance revisions and execution risk on the M&A front.

Analysis

Market structure: Foyston’s 66% cut and Allison’s -28% YoY North American On‑Highway sales signal a near‑term demand shock for new medium/heavy transmissions while aftermarket and defense channels are steady — Defense revenue +47% and 37% EBITDA margin cushion cash flow. Expect pricing power on new builds to be muted for 6–12 months; aftermarket parts and reman programs should capture a larger share of revenue, pressuring OEM suppliers but supporting distributors and defense contractors. Equity technicals will show higher idiosyncratic volatility and likely CDS/widening in the near term, increasing implied vol 30–70% vs index peers.

Risk assessment: Tail risks include a dilutive/difficult Dana off‑highway acquisition (could cause >10–15% EPS dilution over 12–24 months), a deeper commercial cycle extension (truck OEM orders down another 15–25%) or a major warranty/recall charge that erodes the 37% EBITDA margin. Immediate (days) risk is continued institutional selling; short term (weeks–months) hinges on Q4 guidance and acquisition milestones; long term (12–24 months) depends on integration and freight activity recovery. Hidden dependencies: dealer inventory turns, OEM capex timing and defense contract cadence — monitor backlog and book‑to‑bill in next 30–90 days.

Trade implications: Tactical plays: buy downside protection (3–6 month put spreads) or small opportunistic long on sharp dips; target entry < $70 with 12‑month target $100–$120 if margins hold. Pair trades: long ALSN exposure vs short new‑truck OEMs (e.g., PCAR) to isolate aftermarket/defense strength; size 1–2% net. In equities, avoid large outright longs until acquisition financing terms and Q4 guide are confirmed; favor options where volatility is rising.

Contrarian angles: Consensus emphasizes cyclical pain but understates recurring aftermarket cash flow and high EBITDA margins — downside may be capped to a 15–35% further decline (to ~$53–$70) rather than permanent impairment. Historical parallels (commercial vehicle troughs) show 12–18 month recoveries once freight demand normalizes; a mispriced recovery + margin durability could invite activism or take‑private interest given $6.9bn market cap. Watch for acquisition terms or margin guidance surprises that could sharply re‑rate the stock either way.

Key Decisions for Investors

• Establish a small opportunistic long in ALSN (1–2% portfolio) only if price breaks below $70 on >1.5x average daily volume; set a 12‑month target of $100 and hard stop at $58 (approx. 15% risk from entry).
• Buy a 3–6 month put spread to hedge or speculate on further downside: buy ALSN $75 put / sell $60 put (1:1) sized at 0.5–1% portfolio notional; close at 60% of max profit or if ALSN closes >$85 on quarter‑over‑quarter margin improvement.
• Initiate a relative‑value pair: long ALSN (1.5%) vs short PCAR (1.0%) to express aftermarket/defense resilience vs new‑truck cyclicality; enter when ALSN underperformance vs PCAR exceeds 1‑yr mean +1 SD and exit when mean reversion or acquisition clarity occurs (target 3–9 months).
• Reduce cyclical auto‑parts exposure by ~25% and redeploy that weight (+1–3% portfolio) into defense‑exposed industrials or aftermarket distributors within 30 days, given ALSN’s defense growth and broader sector weakness.
• Monitor acquisition and financing: if Dana deal terms imply >10% equity issuance or net leverage rises above 3.5x, reduce or exit ALSN exposure within 7 trading days of disclosure; if acquisition approved with neutral financing and margins maintained, add to longs up to 2% incremental exposure.